Valuation (34%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -5.88 | N/A |
PEG Ratio (TTM) | -2.41 | N/A |
P/S Ratio (TTM) | 0.51 | N/A |
P/B Ratio (TTM) | 1.07 | N/A |
P/FCF Ratio (TTM) | 14.08 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -6.25% | N/A |
ROE (TTM) | -17.57% | N/A |
Net Profit Margin (TTM) | -8.53% | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (30%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -132.91% | -167.88% | N/A |
Revenue | 4.05% | 25.88% | N/A |
Net Income | -141.74% | -170.46% | N/A |
Cash Flow | 15.42% | 37.48% | N/A |
Health (37%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.09 | N/A |
Quick Ratio (TTM) | 1.08 | N/A |
D/E Ratio (TTM) | 1.47 | N/A |
Interest Coverage (TTM) | -0.31 | N/A |
Piotroski F-Score | 5 | N/A |
Altman Z-Score | 0.00 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |